GO:0043231 intracellular membrane-bounded organelle

Intracellular membrane-bounded organelles are the functional compartments that organize eukaryotic cells. According to the Gene Ontology, GO:0043231 describes an organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell; it includes the nucleus, mitochondria, plastids, vacuoles and vesicles, and excludes the plasma membrane. This term captures the fundamental principle that eukaryotic biochemistry is spatially partitioned, allowing incompatible reactions to coexist and enabling precise regulation of transport, signaling and metabolism. Research on these organelles spans membrane trafficking, organelle biogenesis and inter-organelle communication. For example, polarized exocytosis depends on the targeted delivery of vesicles to specific membrane domains, a process essential for cell polarity and tissue morphogenesis. Endocytosis requires coordinated membrane bending and scission to form vesicles that carry cargo into the cell. Beyond canonical eukaryotic organelles, bacteria and archaea also build protein-bounded or lipid-bounded microcompartments that perform specialized functions, indicating deep evolutionary roots for organelle-like organization. In parallel, peroxisomes cooperate with other organelles to maintain lipid and reactive oxygen species homeostasis, and their dysfunction causes developmental and metabolic phenotypes. Micronuclei, which are membrane-bounded structures formed from missegregated chromosomes, are now recognized as drivers of genome instability and inflammation in cancer and aging. Understanding GO:0043231 therefore provides a framework for dissecting how cells build, maintain and repair their internal compartments, and how failures in these processes contribute to human disease.

GO:0043231, intracellular membrane-bounded organelle, is a cellular component term describing any organized intracellular structure that is enclosed by a single or double lipid bilayer and has a distinctive morphology and function. The definition explicitly includes the nucleus, mitochondria, plastids, vacuoles and vesicles, while excluding the plasma membrane. The synonym intracellular membrane-enclosed organelle is used interchangeably. This term is a parent for many specific organelle terms and is used in annotation to indicate that a gene product localizes to or functions within a membrane-bounded compartment inside the cell.

Intracellular membrane-bounded organelles are central to nearly every aspect of cell biology because they create distinct chemical environments that allow specialized functions such as ATP production, protein synthesis, lipid metabolism and waste degradation to occur simultaneously and efficiently. Disruption of organelle structure or function is associated with a broad spectrum of human diseases, including metabolic disorders, developmental defects, cancer and neurodegeneration. Studying how these organelles are assembled, how they communicate and how their membranes are shaped provides mechanistic insight into both normal physiology and disease pathogenesis, and identifies targets for therapeutic intervention.

The following genes and proteins are representative of the machinery that builds, regulates or resides within intracellular membrane-bounded organelles, based on the cited literature.

The formation, maintenance and function of intracellular membrane-bounded organelles are regulated at multiple levels. Membrane trafficking is controlled by small GTPases of the Rab and Arf families, which cycle between active and inactive states to ensure temporal and spatial specificity. Phosphoinositide lipids recruit effector proteins that shape membranes and sort cargo. Organelle biogenesis is regulated transcriptionally; for example, peroxisome proliferation is controlled by PEX genes and their regulators in response to metabolic cues. In addition, stress-responsive pathways such as the unfolded protein response and autophagy modulate organelle turnover and quality control. Micronucleus formation is regulated by mitotic checkpoints and DNA repair pathways, and its persistence can activate innate immune signaling. These regulatory layers ensure that organelles adapt to changing cellular demands.

Defects in mitochondrial membrane transporters and enzymes cause metabolic diseases such as carnitine deficiency, which impairs fatty acid oxidation and energy production. Mutations in SLC25A20 and CPT2 lead to accumulation of acylcarnitines and severe clinical phenotypes, including cardiomyopathy and hypoglycemia. These disorders highlight the importance of mitochondrial membrane-bounded organelles in intermediary metabolism.

Peroxisome dysfunction, caused by mutations in PEX genes, results in a spectrum of diseases including Zellweger syndrome and X-linked adrenoleukodystrophy. Studies in Drosophila have elucidated how peroxisomes cooperate with other organelles, and disruption of this cooperation leads to developmental and metabolic abnormalities. These findings underscore the role of inter-organelle communication in human health.

Micronuclei, which are membrane-bounded organelles formed from missegregated chromosomes, are hallmarks of cancer cells and contribute to tumor heterogeneity and immune activation. They can cause chromothripsis and activate the cGAS-STING pathway, linking nuclear envelope defects to inflammation and tumor progression. Targeting micronucleus formation or clearance is an emerging therapeutic strategy.

Defects in polarized exocytosis and endocytosis underlie diseases ranging from cystic fibrosis to neurological disorders. For example, impaired vesicle trafficking can lead to mislocalization of ion channels and receptors, disrupting tissue function. Understanding the molecular machinery of membrane shaping and fusion is therefore critical for developing treatments.

Fluorescence microscopy, including confocal and super-resolution imaging, is essential for visualizing the morphology, dynamics and localization of intracellular membrane-bounded organelles. Live-cell imaging with tagged proteins (e.g., GFP-RAB8A) allows tracking of vesicle trafficking and organelle interactions. Electron microscopy provides ultrastructural detail of membrane bilayers and organelle shape.

Subcellular fractionation followed by mass spectrometry identifies the protein composition of specific organelles. Proximity labeling (e.g., BioID) can map the interactome of organelle-resident proteins in living cells. These methods reveal how organelle proteomes change under different conditions and identify novel components.

Genome-wide CRISPR knockout screens are powerful for discovering genes required for organelle formation, maintenance or function. For example, screens for micronucleus formation have identified genes involved in chromosome segregation and nuclear envelope integrity. Pooled screens with organelle-specific reporters enable high-throughput discovery.

RNA sequencing and quantitative proteomics measure global changes in gene expression and protein abundance when organelle function is perturbed. These approaches can reveal compensatory pathways and identify biomarkers of organelle stress. Integrating multi-omics data provides a systems-level view of organelle biology.

Researchers studying intracellular membrane-bounded organelle-related genes often need to determine whether a candidate gene is causally involved in organelle biogenesis, function or disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models that answer these questions.

GO:0043231 intracellular membrane-bounded organelle is a foundational concept in cell biology, encompassing the diverse compartments that organize eukaryotic cellular functions. From membrane shaping during endocytosis to peroxisome cooperation and micronucleus formation, these organelles are central to health and disease. Advances in CRISPR-based models and imaging technologies continue to unravel the molecular mechanisms governing their biogenesis and regulation. Understanding these processes offers new opportunities for therapeutic intervention in metabolic, developmental and oncogenic disorders.